Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19
JAMA Internal Medicine (2021) - Comments
doi: 10.1001/jamainternmed.2021.6203  issn: 2168-6106  pubmed: 34617959  issn: 2168-6114 

Alex C. Spyropoulos, Mark Goldin, Dimitrios Giannis, Wassim Diab, Janice Wang, Sameer Khanijo, Andrea Mignatti, Eugenia Gianos, Marc Cohen, Gulru Sharifova, Jeet M. Lund, Alfonso Tafur, Paul A. Lewis, Kevin P. Cohoon, Husneara Rahman, Cristina P. Sison, Martin L. Lesser, Kanta Ochani, Nirav Agrawal, Judith Hsia